Study of EMF Neutrophil Activation effects phase 1

Study of EMF Neutrophil Activation effects phase 1 - Neutrostim

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON50859

Enrollment

Registered

2021-05-31

Start date

2021-06-21

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention and/or reduction of infectious disease

Interventions

30 minutes exposure to a weak electromagnetic field with a specific signal content. The field strength is approximately 5 micro Tesla, which is a factor of 10 below the ICNIRP / EU safety guideline.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A group of volunteers, diverse in age and gender

Exclusion criteria

Exclusion criteria: Immune related disease pregnancy

Design outcomes

Primary

Measure	Time frame
Increased neutrophil granularization	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)